Vimta Labs Ltd
Vimta Labs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Vimta Labs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Vimta Labs Ltd Share Price Chart
VIMTALABS at 10 Jul 2026 05:17 PM Healthcare Services
566.10 +7.20(+1.29%)
Lowest Today 558.30
Highest Today 570.00
Today's Open 560.00
Prev. Close 558.90
52 Week High 902.65
52 Week Low 376.05
Vimta Labs Ltd Fundamentals
Traded Volume: 1,18,565
Market Cap(Cr): 2,529.73
Avg Traded Price 564.40
1 Year return 22.56%
Upper Circuit 570
Lower Circuit 558.3
P/E TTM 33.00
P/B Ratio 5.464
Traded Value(Cr) 671.20
EPS TTM 17.346
Book value/Share 102.280
Dividend Yield 1Y 0.35%
Vimta Labs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Vimta Labs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Vimta Labs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -3.50%
1M +7.25%
3M +29.26%
1Y +22.56%
YTD -7.08%
Vimta Labs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Vimta Labs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 2.47L
Day Before Yesterday 1.39L
1W Avg 1.75L
1M Avg 3.19L
3M Avg 3.24L
Vimta Labs Ltd Technical Details
Vimta Labs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 536
Support 2 514
Support 3 495
Pivot Point : 556
Resistance 1 578
Resistance 2 597
Resistance 3 620
Vimta Labs Ltd Corporate Actions
Vimta Labs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Vimta Labs Ltd’s capital allocation strategies.
All
Ex-Date 18-Jun-2026 Type D Description 2.00/share@100.00% Record Date 18-Jun-2026 Ratio 100.00
Ex-Date 13-Jun-2025 Type B Description share@1:1 Record Date 13-Jun-2025 Ratio 1:1
Ex-Date 30-May-2025 Type D Description 2.00/share@100.00% Record Date 30-May-2025 Ratio 100.00
Ex-Date 11-Jul-2024 Type D Description 2.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 21-Jun-2023 Type D Description 2.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 16-Jun-2022 Type D Description 2.00/share@100.00% Record Date 18-Jun-2022 Ratio 100.00
Ex-Date 25-Jun-2021 Type D Description 2.00/share@100.00% Record Date 28-Jun-2021 Ratio 100.00
Ex-Date 18-Jul-2019 Type D Description 2.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 14-Aug-2018 Type D Description 2.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 25-Aug-2016 Type D Description 1.00/share@50.00% Record Date - Ratio 50.00
Ex-Date 06-Aug-2015 Type D Description 1.00/share@50.00% Record Date - Ratio 50.00
Ex-Date 27-Jun-2014 Type D Description 2.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 23-May-2013 Type D Description 0.60/share@30.00% Record Date - Ratio 30.00
Ex-Date 15-Sep-2011 Type D Description 0.40/share@20.00% Record Date - Ratio 20.00
Ex-Date 23-Sep-2010 Type D Description 0.80/share@40.00% Record Date - Ratio 40.00
Ex-Date 10-Sep-2009 Type D Description 0.80/share@40.00% Record Date - Ratio 40.00
Ex-Date 28-Aug-2008 Type D Description 0.80/share@40.00% Record Date - Ratio 40.00
Ex-Date 02-Aug-2007 Type D Description 0.80/share@40.00% Record Date - Ratio 40.00
Dividends
Announcement Date 18-Jun-2026 Ex Dividend Date 18-Jun-2026 Dividend(%) 100
Announcement Date 30-May-2025 Ex Dividend Date 30-May-2025 Dividend(%) 100
Announcement Date 11-Jul-2024 Ex Dividend Date 11-Jul-2024 Dividend(%) 100
Announcement Date 21-Jun-2023 Ex Dividend Date 21-Jun-2023 Dividend(%) 100
Announcement Date 16-Jun-2022 Ex Dividend Date 16-Jun-2022 Dividend(%) 100
Announcement Date 25-Jun-2021 Ex Dividend Date 25-Jun-2021 Dividend(%) 100
Announcement Date 18-Jul-2019 Ex Dividend Date 18-Jul-2019 Dividend(%) 100
Announcement Date 14-Aug-2018 Ex Dividend Date 14-Aug-2018 Dividend(%) 100
Announcement Date 25-Aug-2016 Ex Dividend Date 25-Aug-2016 Dividend(%) 50
Announcement Date 06-Aug-2015 Ex Dividend Date 06-Aug-2015 Dividend(%) 50
Announcement Date 27-Jun-2014 Ex Dividend Date 27-Jun-2014 Dividend(%) 100
Announcement Date 23-May-2013 Ex Dividend Date 23-May-2013 Dividend(%) 30
Announcement Date 15-Sep-2011 Ex Dividend Date 15-Sep-2011 Dividend(%) 20
Announcement Date 23-Sep-2010 Ex Dividend Date 23-Sep-2010 Dividend(%) 40
Announcement Date 10-Sep-2009 Ex Dividend Date 10-Sep-2009 Dividend(%) 40
Announcement Date 28-Aug-2008 Ex Dividend Date 28-Aug-2008 Dividend(%) 40
Announcement Date 02-Aug-2007 Ex Dividend Date 02-Aug-2007 Dividend(%) 40
Bonus
Record Date 13-Jun-2025 Ex-Bonus Date 13-Jun-2025 Ratio 1:1
Splits
No Split has been declared by VIMTALABS
Others
Rights No Rights has been declared by VIMTALABS
Vimta Labs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Vimta Labs Ltd with leading peers in the healthcare sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Vimta Labs Ltd's relative performance and valuation against major competitors.
Stock Name Nephrocare Health Services Ltd ₹649.00 (+2.46%) M. Cap (Cr) 65.12 1 Yr Return (%) NaN% P/E (TTM) PB Ratio 5.83
Stock Name Entero Healthcare Solutions Ltd ₹1210.90 (-0.45%) M. Cap (Cr) 52.70 1 Yr Return (%) +1.67% P/E (TTM) 45.81 PB Ratio 3.12
Stock Name Medi Assist Healthcare Services Ltd ₹357.80 (-0.25%) M. Cap (Cr) 26.73 1 Yr Return (%) -36.57% P/E (TTM) 30.39 PB Ratio 3.19
Stock Name Vimta Labs Ltd ₹566.10 (+1.29%) M. Cap (Cr) 25.30 1 Yr Return (%) +22.56% P/E (TTM) 32.64 PB Ratio 5.54
Stock Name Krsnaa Diagnostics Ltd ₹556.65 (-0.04%) M. Cap (Cr) 18.06 1 Yr Return (%) -30.03% P/E (TTM) 17.80 PB Ratio 1.84
Stock Name Suraksha Diagnostic Ltd ₹264.30 (+0.34%) M. Cap (Cr) 13.76 1 Yr Return (%) -17.39% P/E (TTM) 42.77 PB Ratio 5.62
Stock Name One Global Service Provider Ltd ₹610.00 (-1.29%) M. Cap (Cr) 11.92 1 Yr Return (%) +129.24% P/E (TTM) 17.16 PB Ratio 8.44
Vimta Labs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Vimta Labs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 147.14 Mar 2025 94.61 Mar 2024 59.06 Mar 2023 86.51 Mar 2022 58.67
PARTICULARS Investing Activities Mar 2026 -129.67 Mar 2025 -75.54 Mar 2024 -74.60 Mar 2023 -56.93 Mar 2022 -37.88
PARTICULARS Financing Activities Mar 2026 -10.35 Mar 2025 -16.68 Mar 2024 -1.90 Mar 2023 -10.66 Mar 2022 -16.14
PARTICULARS Net Cash Flow Mar 2026 7.13 Mar 2025 2.40 Mar 2024 -17.45 Mar 2023 18.92 Mar 2022 4.64
Vimta Labs Ltd Shareholding Pattern
This shows the ownership breakdown of Vimta Labs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 35.85%
Public 59.12%
Other Institutions 0.13%
FII 4.89%
Mutual Funds N/A%
About Vimta Labs Ltd
Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.In 2024-25, Emtac Laboratories Pvt. Ltd., the 100% owned subsidiary got merged with the Company effective from 01 April, 2024, thereby consolidating its presence in the Electronics and Electrical testing.The Company has entered into niche segment of contract research & development of biologics and peptides in FY2025-26. The Memorandum of Association (MoA) of the Company was amended, with the Main Object Clause to undertake activities in the Biologics Contract Research and Development and Manufacturing (CDMO) segment, including contract development, analytical testing, and other R&D services relating to biologics and peptide-based drug development and manufacturing support in FY 2025-26.
Executive Chairman
S P Vasireddi
Registered office Plot No 141/2 & 142, IDA Phase II Cherlapally, Hyderabad, Telangana, 500051
FAX :91-40-27264141
Background
Incorporation Year 1990
Face Value ₹2.00
Market Lot 1
FAQs on Vimta Labs Ltd
How to buy Vimta Labs Ltd shares?
To buy Vimta Labs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Vimta Labs Ltd?
The company has a market capitalization of ₹2,529.73.
What is the PE & PB ratio of Vimta Labs Ltd?
PE is 33 and PB is 5.464.
What is the Vimta Labs Ltd dividend for 2025–26?
For the 2025–26 financial year, Vimta Labs Ltd declared a final dividend of 0.35% per share.